Viewing Study NCT01574235


Ignite Creation Date: 2025-12-24 @ 10:04 PM
Ignite Modification Date: 2026-03-07 @ 10:18 PM
Study NCT ID: NCT01574235
Status: COMPLETED
Last Update Posted: 2015-07-28
First Post: 2012-04-04
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Nivestim® (Filgrastim) Tolerance in Patients Treated by Toxic Chemotherapeutic Agents
Sponsor: Hospira, now a wholly owned subsidiary of Pfizer
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumors View
None Malignant Hemopathy View
None Chemotherapy-induced Febrile Neutropenia (FN) View
Keywords: